Completed
Bioequivalence Study of Fulvestrant Injection 50 mg/mL in Healthy Post-menopausal Female Subjects
NCT02795039
- Conditions
- Healthy
- Locations
-
- Lambda Therapeutic Research Inc. Toronto, Ontario, Canada
- BioPharma Services Inc. Toronto, Ontario, Canada
- Algorithme Pharma Inc. Mount Royal, Quebec, Canada